Andreas Rogalewski
Overview
Explore the profile of Andreas Rogalewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Schabitz W, Rogalewski A, Hagemeister C, Bien C
Neurology
. 2014 Nov;
83(24):2309-11.
PMID: 25378669
No abstract available.
22.
Schneider A, Rogalewski A, Wafzig O, Kirsch F, Gretz N, Kruger C, et al.
Exp Transl Stroke Med
. 2014 Feb;
6(1):3.
PMID: 24528872
Background And Purpose: Both the immobilization of the unaffected arm combined with physical therapy (forced arm use, FAU) and voluntary exercise (VE) as model for enriched environment are promising approaches...
23.
Rogalewski A, Dittgen T, Klugmann M, Kirsch F, Kruger C, Pitzer C, et al.
PLoS One
. 2010 May;
5(5):e10737.
PMID: 20505770
We have previously identified Semaphorin 6a (Sema6A) as an upregulated gene product in a gene expression screen in cortical ischemia [1]. Semaphorin 6a was regulated during the recovery phase following...
24.
Popa-Wagner A, Stocker K, Balseanu A, Rogalewski A, Diederich K, Minnerup J, et al.
Stroke
. 2010 Apr;
41(5):1027-31.
PMID: 20360546
Background And Purpose: In aged humans, stroke is a major cause of disability for which no neuroprotective measures are available. Granulocyte-colony stimulating factor (G-CSF), a member of the cytokine family...
25.
Minnerup J, Heidrich J, Rogalewski A, Schabitz W, Wellmann J
Stroke
. 2009 Jun;
40(9):3113-20.
PMID: 19542052
Background And Purpose: Erythropoietin (EPO) was explored regarding its suitability as a candidate stroke drug in animal experimental studies. We performed a meta-analysis to obtain an overall impression of the...
26.
Rogalewski A, Kraus J, Hasselblatt M, Kraemer C, Schabitz W
Neuropsychiatr Dis Treat
. 2009 Mar;
3(6):987-91.
PMID: 19300637
We report a case of acute demyelinating encephalitis that occurred after viral vaccination against hepatitis A-, hepatitis B-, and poliovirus and vaccination against bacterial toxins of diphtheria and tetanus. After...
27.
Minnerup J, Heidrich J, Wellmann J, Rogalewski A, Schneider A, Schabitz W
Stroke
. 2008 Apr;
39(6):1855-61.
PMID: 18403735
Background And Purpose: Recent reports have described the efficacy of the hematopoietic growth factor granulocyte-colony stimulating factor (G-CSF) in animal stroke models. Early clinical multicenter trials evaluating the effect of...
28.
Ritter M, Brach S, Rogalewski A, Dittrich R, Dziewas R, Weltermann B, et al.
Neurol Res
. 2007 May;
29(5):476-9.
PMID: 17535554
Background: Poor knowledge of stroke symptoms within the general population might be responsible for significant delay between symptom onset and hospital admission in most stroke patients. Methods: We prospectively evaluated...
29.
Rogalewski A, Schneider A, Ringelstein E, Schabitz W
Stroke
. 2006 Mar;
37(4):1129-36.
PMID: 16527996
Background And Purpose: Stroke remains a common medical problem with importance attributable to the demographic changes in industrialized societies. Summary Of Review: After years of setbacks, acute stroke therapy has...
30.
Rogalewski A, Evers S
Headache
. 2005 Feb;
45(2):167-9.
PMID: 15705126
We report a male patient with a right internal carotid artery (ICA) dissection and a consecutive hemicrania continua (HC) fulfilling the criteria of the International Headache Society. This is the...